[EN] THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSITIONS DE PHÉNÉTHYLAMINE THÉRAPEUTIQUE ET MÉTHODES D'UTILISATION
申请人:CYBIN IRL LTD
公开号:WO2022038170A1
公开(公告)日:2022-02-24
There are disclosed deuterated 2C-X phenethylamine compounds, the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as tablet compositions and kits containing the compounds, methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders with the compounds of the invention.
The Synthesis of Some Analogs of the Hallucinogen 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane (DOM)
作者:Ronald T. Coutts、Jerry L. Malicky
DOI:10.1139/v73-210
日期:1973.5.1
The synthesis of a series of 4-substituted 1-(2,5-dimethoxyphenyl)-2-aminopropanes, in which the 4-substituent is Br, Cl, I, NO2, NH2, and NHAc, is described. These compounds are analogs of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), a known hallucinogen. A synthesis of N-(2,5-dimethoxy-4-methylphenethyl)hydroxylamine, the N-hydroxy homolog of DOM, is also reported. Brief reference is made
Ring-substituted β-methoxyphenethylamines: a new class of psychotomimetic agents active in man
作者:D Lemaire、P Jacob、A T Shulgin
DOI:10.1111/j.2042-7158.1985.tb03072.x
日期:2011.4.12
Four members of a newclass of psychotomimetic agents have been synthesized and evaluated in man. These compounds, which incorporate a beta-methoxy group onto a beta-phenethylamine sidechain, are the first reported psychotomimetics which are structural analogues of the neurotransmitter noradrenaline. These substances are more potent than the corresponding phenethylamines (lacking a beta-methoxy group)